Drug application
POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC)
Drugs@FDA ANDA 217726 · SOMERSET THERAPS LLC
Key facts
| Drug name | POTASSIUM PHOSPHATES |
|---|---|
| Active ingredients | POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM PHOSPHATE, MONOBASIC |
| Application type | ANDA |
| Application number | 217726 |
| Company | SOMERSET THERAPS LLC |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jul 11, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.